RLAY is trading 4.5% up at $18.22 as the stock extends a multi-day rebound driven by improving sentiment toward biotech and growth names.
- Shares have climbed steadily since June 17, recovering significantly from the mid-$14 range seen earlier this month.
- The move appears to be a continuation of recent momentum, as there are no fresh company-specific headlines, filings, or rating changes reported this morning.